RSS News

Pharmaceutical Industry

Drugs Licensed

In weight loss battle, Novo and Lilly face growing offensive from licensed copies - Reuters

F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea - The New York Times

Department of Drug and Alcohol Programs - Governor Tom Wolf

Pediatric Oncology Drug Approvals - FDA.gov

Officers say Pink Hill man jailed after finding stolen license plate & drugs - WITN

Woman accused of selling black market weight loss drugs, police say - WABI

The Medical Minute: What to know about Ozempic and weight loss drugs - Penn State Health News

Massachusetts Implements Long-Awaited Licensing Regime for Out-of-State Pharmacies - The National Law Review

FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease - Yale Medicine

Drugs Patents

Teva loses US appeal to keep inhaler patents on FDA protected drug list - Reuters

Sponsored Content: The Connection Between Patents and High Drug Prices - POLITICO

Opinion: Lessons From Humira on How to Tackle Unjust Extensions of Drug Monopolies With Policy - BioSpace

$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents - UCLA

How big pharma keeps affordable drugs out of reach – video - The Guardian

Should Patents Create Incentives for Failure? - The Regulatory Review

Clearing Dense Drug-Patent Thickets - nejm.org

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP - AccessWire

RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies

Drugs Generics

Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access - FDA.gov

Industrial Policy To Reduce Prescription Generic Drug Shortages - Center For American Progress

RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies

Why do hospitals keep running out of generic drugs? : Planet Money - NPR

Making affordable generics more reliable - The Hindu

The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat - STAT

U.S. Generic Drugs Market Size to Surpass USD 188.44 Bn by 2032 - BioSpace

Saudi Arabia Generic Drugs Market Report 2024, By Region, Competition, Forecast and Opportunities to 2029 - GlobeNewswire

Savings through generic drug usage in the U.S. 2008-2023 - Statista

FDA Food and Drug Administration

FDA Finalizes Updated “Healthy” Nutrient Content Claim - FDA.gov

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity - Investors | Eli Lilly and Company

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea - NPR

Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea - Reuters

Popular Arthritis Drug For Dogs May Have Severe Side Effects, F.D.A. Says - The New York Times

US FDA approves Novo Nordisk's bleeding disorder drug - Reuters.com

The FDA restricts a psychoactive mushroom used in some edibles - WHYY

"100% successful" cancer drug gets landmark FDA approval - New Atlas

Ionis wins FDA approval for a rare disease therapy that lowers triglycerides - STAT

Pharmaceutical Companies

Congressional Drug-Pricing Reforms Upend Trump’s Strategy - The American Prospect

How big pharma keeps affordable drugs out of reach – video - The Guardian

GoodRx Discusses the Evolving Healthcare Landscape and Industry Trends Shaping Patient Experience - FiercePharma

These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy? - Yahoo Finance

Hoping for Allies Among Trump’s Health Picks, Pharma Faces Hostility - The New York Times

RFK Jr vow to purge FDA sets up collision with Big Pharma - Reuters.com

The Dangerous Narrative of the “War on Cartels” - Georgetown Journal of International Affairs

20 Pharmaceutical Companies in Germany to Know - Built In

Giant Companies Took Secret Payments to Allow Free Flow of Opioids - The New York Times

Retail Pharmacies

How PBM Reform Could Help Walgreens And Other Retail Pharmacies - Forbes

Small pharmacies are being driven out of business. ‘We can’t afford to stay’ - Sunbury Daily Item

Nearly 1 in 3 Retail Pharmacies Have Closed Since 2010 - UC Berkeley School of Public Health

One of Portland's remaining independent pharmacy persists despite industry pressures - KGW.com

Experts: Operational challenges the leading cause of drug store closures - Chain Store Age

Pharmacy Technology AI Solutions - Pharmacy Practice News

About 1 in 3 retail pharmacies have closed since 2010: study - Healthcare Dive

Study: One in three retail pharmacies closed between 2010 and 2021 - Healthcare Brew

Four ways retail pharmacies are evolving for a safer, digital future - Wolters Kluwer

Drug Marketing

FDA says knockoff versions of Lilly obesity drug must come off the market - ABC News

Revenue of leading pharmaceutical markets in Europe in 2023 - Statista

Woman accused of selling black market weight loss drugs, police say - WSAZ

Otsuka falls foul of most serious drug marketing breach, again, as Jinarc training site comes under fire - FiercePharma

6 things you should know about drug marketing authorizations (MA) - Servier

Illegal black market weight loss drugs sold out of Mid-South home and clinics, drug task force says - FOX13 Memphis

Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica

Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency - Frontiers

5 GLP-1 marketing trends as brands jump on weight loss drug craze - Ad Age